AEON

NYSEAMERICAN 已收盘

AEON Biopharma

0.12 USD
▼-0.01-7.59%
盘后 0.12 +0.49%
2026-11-20
市值
$6.14M
市盈率
—
EPS
-0.98
股息率
—
52 周区间
0.11 – 1.45
成交量
1.17M
Beta
0.69
目标价
1.82
52W 低 0.1152W 高 1.45
价格走势

公司简介

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine. It also develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is base...